Utah Medical Products UTMD Ratios (2010-2026)

NASDAQ UTMD
$69.95 +0.23 (+0.33%)
As of: Sep 10, 2026 · 10:53 AM EDT
Reported Financials

Utah Medical Products Quarterly Ratios

Periods 65 quarters
Latest Jun 2026

Utah Medical Products reported a gross margin of 55.79% and a net margin of 31.49% for the quarter ended Jun 2026. These financial ratios cover 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
64.21%62.82%61.13%60.70%63.19%61.34%62.64%60.15%58.85%57.55%59.66%60.13%57.99%58.13%57.03%56.21%57.11%58.20%60.56%55.79%
EBT Margin
41.02%40.12%36.76%38.72%41.21%41.19%40.89%40.20%38.23%40.68%42.31%40.49%41.77%39.47%39.73%38.54%33.72%34.34%36.48%38.53%
EBIT Margin
40.55%39.72%36.70%37.66%39.68%37.35%35.46%34.39%31.74%31.98%34.24%33.06%33.41%32.00%32.47%32.11%26.61%26.99%29.41%31.06%
EBITDA Margin
40.55%39.72%36.70%37.66%39.68%37.35%35.46%34.39%31.74%31.98%34.24%33.06%33.41%32.00%32.47%32.11%26.61%26.99%29.41%31.06%
Operating Margin
40.55%39.72%36.70%37.66%39.68%37.35%35.46%34.39%31.74%31.98%34.24%33.06%33.41%32.00%32.47%32.11%26.61%26.99%29.41%31.06%
Net Margin
33.46%32.00%28.68%30.56%33.04%30.27%33.66%32.64%31.47%29.72%34.89%33.20%35.61%27.98%31.32%30.62%26.81%21.58%29.86%31.49%
FCF Margin
47.04%36.66%39.02%34.40%40.66%41.56%54.89%35.70%39.46%42.50%46.33%25.50%37.65%31.98%44.08%28.35%39.25%37.24%34.16%14.64%
Efficiency
Inventory AverageInventory Avg.
6.21M6.45M6.98M7.35M7.82M8.56M9.38M10.03M9.91M9.65M9.41M9.15M9.08M8.96M8.73M8.44M8.18M8.03M8.33M8.86M
Assets AverageAssets Avg.
118.27M117.69M117.72M117.98M117.28M121.14M125.82M129.12M130.86M133.35M135.45M132.74M129.86M126.12M122.53M121.66M121.39M122.26M123.46M124.48M
Invested CapitalInvested Cap.
128.61M117.71M117.32M117.53M118.49M119.49M120.58M122.23M
Asset Utilization RatioAsset Util.
0.410.420.430.430.440.430.420.400.390.380.360.350.340.320.320.320.320.320.300.29
Leverage & Solvency
Debt Ratio
0.000.000.000.000.000.000.00
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
4.050.493.874.073.913.943.933.673.423.633.193.392.472.993.042.662.002.632.72
FCF Payout RatioFCF Cover
0.181.760.230.200.190.160.230.220.200.210.410.280.350.240.350.260.290.330.79
Dividend YieldDiv. Yield
0.31%2.28%0.34%0.34%0.29%0.31%0.32%0.34%0.35%0.43%0.46%0.46%0.51%0.55%0.55%0.49%0.55%0.50%0.45%
Payout Ratio
0.252.020.260.250.260.250.250.270.290.280.310.300.410.330.330.380.500.380.37
Valuation
Price to EarningsP/E
80.5588.4692.9475.8972.2588.7681.5980.5379.3183.3764.5067.7064.6280.0260.4660.0676.6891.3475.8081.74
Price to SalesP/S
26.9528.3026.6523.1923.8726.8727.4626.2924.9624.7822.5022.4823.0122.3918.9418.3920.5619.7122.6325.74
Price to BookP/B
3.083.413.012.902.863.192.912.782.522.382.001.881.851.751.571.561.711.491.641.80
Enterprise Value
274.45M304.53M262.57M245.16M239.74M289.67M262.91M253.60M223.88M212.68M161.33M144.55M141.79M122.03M100.54M100.88M117.49M92.53M109.97M132.04M
EV to EBIT
53.8459.3658.0648.4846.6357.1359.2357.3156.4153.9341.5542.0442.4141.6531.8931.5645.0037.9142.8749.84
EV to EBITDA
53.8459.3658.0648.4846.6357.1359.2357.3156.4153.9341.5542.0442.4141.6531.8931.5645.0037.9142.8749.84
Market Capitalization
338.77M365.50M328.44M311.39M309.25M364.72M343.83M338.22M312.09M305.55M255.14M233.77M230.24M205.00M183.87M183.05M201.76M178.29M197.38M219.56M
Price to FCFP/FCF
57.2877.2168.3067.4158.7064.6450.0373.6463.2458.2948.5688.1561.1270.0142.9664.8752.3952.9466.26175.79
EV to FCF
46.4164.3354.6053.0845.5151.3438.2655.2245.3740.5730.7154.5137.6441.6823.4935.7530.5127.4736.92105.71
EV to CFO
45.8161.0652.0350.7442.8951.0038.0251.6243.7239.8930.5852.3336.7741.5522.5235.1130.3026.6135.3795.47
Return Ratios
Return on Sales [ROS]ROS
40.55%39.72%36.70%37.66%39.68%37.35%35.46%34.39%31.74%31.98%34.24%33.06%33.41%32.00%32.47%32.11%26.61%26.99%29.41%31.06%
Return on Capital Employed [ROCE]ROCE
15.92%16.57%17.48%17.45%17.88%17.18%16.46%15.39%14.13%13.04%12.48%11.83%11.55%11.11%10.88%10.57%10.04%9.53%9.01%8.39%
Return on Invested Capital [ROIC]ROIC
8.71%8.48%7.78%7.25%6.86%6.48%
Return on Assets [ROA]ROA
11.72%12.56%13.00%13.54%13.68%13.23%13.28%13.01%12.58%12.01%11.63%11.31%11.27%10.73%10.30%10.04%9.29%8.73%8.29%7.93%